Stay updated on Pembrolizumab in Biliary Tract Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Biliary Tract Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor site version update with no visible changes to the study page.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 has been added; the page content and purpose remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedThe update is a minor version bump from v3.4.0 to v3.4.1 with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check105 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Biliary Tract Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Biliary Tract Cancer Clinical Trial page.